Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

1275 ArticlesStocks

33 / 128

Infosys Has A Lacklustre Result But Option Sellers Rejoice

Infy results have been ordinary. You could write a lot about how their margins went up X basis points or their “guidance” was down (or up, ...
Infy-Employees.png

Exclusive: We Reveal The Observations Made By US FDA’s Inspection Of Granules OmniChem's Vizag Facility

True to our promise of keeping a tab on the regulatory inspections of Indian Pharmaceutical companies, we are happy to get our hands on the Form 483 issued ...
Granules-OmniChem.jpg

2016 in Review: The Top 10 Dividend Yielding Companies

As part of our year-end summaries, we look at the top 10 dividend yield performers for 2016. You can catch our earlier series here: 2016 in review: The top 10 ...
Stocks-with-Highest-Diveidend-Yield-2016.png

Tata Motors Sales Growth At 2.4%, Exports Driven By Strong Demand For Commercial Vehicles

Away from all the Tata-Mistry Tamasha, Tamo snatched the Army fleet contract from Maruti. Maruti’s iconic Gypsy will be replaced by Tata Safari Storme with ...
Tata-army-Truck.jpg

M&M Farm Equipment Sales Growth At 9.2%, Exports Increase By Over 200 Units

M&M FES reported sales of 14,047 units in December, 2016 against 12,868 units during the same time last year resulting in a growth of 9.2%. Domestic ...
Mahindra-295-di-tractor-1.jpg

2016 in review: The top 10 mid-cap performers!

As part of our year-end summaries, we look at the top 10 mid-cap performers for 2016 (ending 23-Dec). You can catch our earlier series here: 2016 in ...
2016-in-Review-The-Top-10-Mid-Cap-Performers-of-the-Year.png

We Reveal The Form 483 Issued By US FDAs Inspection Of Divis Laboratories Unit-II At Visakhapatnam

Here is our coverage of the Form 483 issued by the US FDA from the inspection of Divis Laboratories Unit-II located at Visakhapatnam. You can catch all our ...
Divis-Laboratories-FDA-Inspection.png

2016 in Review: The Top 10 Large Cap Performers!

As part of our year-end piece, we look at the Top 10 Large-cap performers for 2016 (ending 23-Dec). You can catch our earlier series here: 2015 in Review: ...
2016-in-Review-The-Top-10-Large-Cap-Performers-of-the-Year-2.png

Metal and Energy best performers in 2016, Pharma and IT worst

The new year is upon us. How did the different sectors in our market perform in 2016? Let’s take a look at the returns of sectoral indices since the ...
Indices-Returns-2016.png

Exclusive: We Reveal The Observations Made By US FDA’s Inspection Of Sun Pharma’s Halol Facility

True to our promise of keeping a tab on the US FDAs inspection of Sun Pharma’s Halol facility, we are happy to get our hands on the Form 483 issued for ...
US-FDA-Sun-Pharma-Halol-Form-483-2.png